Jiahui Shan is affiliated with the Department of Radiation Oncology, Peking University Cancer Hospital. Her research focuses on radiation oncology, thoracic oncology, and real-world clinical research in limited-stage small cell lung cancer. She has participated in multicenter LS-SCLC cohort studies and is familiar with patient screening, clinical data cleaning, variable definition, endpoint setting, statistical analysis, manuscript writing, and peer-review response. Her research interests include concurrent chemoradiotherapy for LS-SCLC, PCI versus MRI surveillance strategies, radiotherapy dose and fractionation, SIB techniques, and durvalumab consolidation therapy. She has contributed to several manuscripts published, accepted, or under revision in journals including BMC Cancer, Frontiers in Oncology, Practical Radiation Oncology, Therapeutic Advances in Medical Oncology, and Translational Lung Cancer Research. She has also presented posters at FARO/THASTRO, ESMO Immuno-Oncology Congress, and CSTRO. Her methodological experience includes Kaplan–Meier analysis, Cox regression, IPTW, SMD assessment, landmark analysis, competing-risk analysis, and clinical outcome evaluation.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none